A vaccine against coronavirus has shown an encouraging immune response in older adults.

Hopes of controlling the virus amongst those most at risk have been raised by the latest vaccine study.

Phase two of The Lancet's research has found that an Oxford developed vaccine produces an "encouraging" immune system response for those in their sixties and seventies.

The AstraZeneca vaccine has recently been tested on 560 healthy volunteers.

A peer review of Oxford's vaccine was carried out by The Lancet, finding that the same immune response was created in high risk groups as it was in young people.

Hopes are also high for a Pfizer and BioNTech vaccine which boasts 94 per cent protection against Covid-19. A jab is also being developed by Moderna, both vaccines are in phase three of trials.